1-6 of 6
Lingling Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Lenalidomide, PD-1 Monoclonal Antibodies Combined with Orelabrutinib in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase II Study

Lingling Wang, Yongfen Huang, Hui Chen, Hao Xu, Yuexin Cheng, Yuqing Miao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6488.
https://doi.org/10.1182/blood-2024-198309
Published: 2024
Journal Articles

Clinical and Genetic Landscape of Peripheral T-Cell Lymphomas in Chinese Population: A Retrospective Study

Lingling Wang, Lei Yang, Fangshu Guan, Jing Chen, Yuexin Cheng, Yuqing Miao, Jingsong He, Zhen Cai, He Huang, Yi Zhao
Journal: Blood
Blood (2024) 144 (Supplement 1): 6181.
https://doi.org/10.1182/blood-2024-199127
Published: 2024
Journal Articles

Efficacy of Daratumumab in 34 Patients with Newly Diagnosed Multiple Myeloma in Real World Study

Xiangxin Li, Lingling Wang, Fanglin Li, Hai Zhou, Na Liu, Shuang Yu, Qi Feng, Hao Li, Luqun Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6680.
https://doi.org/10.1182/blood-2023-182649
Published: 2023
Journal Articles

Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Asian Patients with Newly Diagnosed Multiple Myeloma: Final Analysis of the Phase 3 Octans Study

Weijun Fu, Soo-Mee Bang, Honghui Huang, Kihyun Kim, Wei Li, Gang An, Je-Jung Lee, Zhen Cai, Jie Jin, Yafei Wang, Chor Sang Chim, Robin Carson, Rui Liu, Lingling Wang, Man Zhao, Xi Chen, Canchan Cui, Jian Hou, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3388.
https://doi.org/10.1182/blood-2023-181063
Published: 2023
Journal Articles

Efficacy and Safety of Lenalidomide, Anti-PD-1 Antibody Combined with Orelabrutinib or Rituximab in the Treatment of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Miao Qing, Yongfen Huang, Can Chen, Lingling Wang, Jun Feng, Chuanhai Xu, Yuexin Cheng, Jianming Dong, Linlin Zhang, Hao Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 3769–3770.
https://doi.org/10.1182/blood-2022-167998
Published: 2022
Journal Articles

Bortezomib: Once-Weekly 1.6mg/m 2 Maybe a Better Choice Compared with Twice-Weekly 1.3mg/m 2 in Newly Dignosed Multiple Myeloma

Yubin Li, Fangfang Li, Wangshan Song, Zhumei Zhan, Xiangxin Li, Lingling Wang, Fanglin Li, MD, Ming Hou, MD PhD, Hao Li, MD, Luqun Wang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5558.
https://doi.org/10.1182/blood-2019-125714
Published: 2019